×

Sarepta awaits drug approval

12:11 PM ET Fri, 20 May 2016

CNBC's Meg Tirrell talks about whether the FDA will approve Sarepta's Muscular Dystrophy drug and what could happen to the company's stock. The "FMHR" traders debate the trade.